FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stereotaxis's Free Cash Flow for the
three
months ended in Dec. 2023 was $-2.44 Mil. Stereotaxis's Revenue for the
three
months ended in Dec. 2023 was $4.57 Mil. Therefore, Stereotaxis's FCF Margin % for the quarter that ended in Dec. 2023 was -53.43%.
As of today, Stereotaxis's current FCF Yield % is -4.86%.
The historical rank and industry rank for Stereotaxis's FCF Margin % or its related term are showing as below:
STXS'
s FCF Margin % Range Over the Past 10 Years
Min: -38.35 Med: -15.67 Max: -7.12
Current: -35.5
During the past 13 years, the highest FCF Margin % of Stereotaxis was -7.12%. The lowest was -38.35%. And the median was -15.67%.
STXS's FCF Margin % is ranked worse than 66.63% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: -7.19
vs STXS: -35.50
Stereotaxis FCF Margin % Historical Data
The historical data trend for Stereotaxis's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Stereotaxis's FCF Margin %
For the Medical Instruments & Supplies subindustry, Stereotaxis's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stereotaxis's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Stereotaxis's FCF Margin % falls into.
Stereotaxis FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Stereotaxis's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stereotaxis FCF Margin % Related Terms
Thank you for viewing the detailed overview of Stereotaxis's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STXS has been successfully added to your 